Evidence map›Paper›PMID 28927269›Full record

ArticleJournal of proteome research2017

Discovery of Tamoxifen and N-Desmethyl Tamoxifen Protein Targets in MCF-7 Cells Using Large-Scale Protein Folding and Stability Measurements.

Ryenne N Ogburn, Lorrain Jin, He Meng, Michael C Fitzgerald

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Stability-based approaches in chemoproteomics.Expert reviews in molecular medicine · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Chemoproteomics for Plasmodium Parasite Drug Target Discovery.Chembiochem : a European journal of chemical biology · 2021
    Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ryenne N OgburnDepartment of Chemistry, Duke University , Durham, North Carolina 27708, United States.
Lorrain JinDepartment of Chemistry, Duke University , Durham, North Carolina 27708, United States.
He MengDepartment of Chemistry, Duke University , Durham, North Carolina 27708, United States.
Michael C FitzgeraldDepartment of Chemistry, Duke University , Durham, North Carolina 27708, United States.ORCID 0000-0002-6719-4722
Duke University · US

Funding

Analysis of Protein-Ligand Binding on the Proteomic ScaleR01GM084174 · NIGMS · DUKE UNIVERSITY · PI FITZGERALD, MICHAEL C · 2009 to 2017
$2.6M
NIGMS NIH HHS R01 GM084174
6 · The paper itself

Abstract

The proteins in an MCF-7 cell line were probed for tamoxifen (TAM) and n-desmethyl tamoxifen (NDT) induced stability changes using the Stability of Proteins from Rates of Oxidation (SPROX) technique in combination with two different quantitative proteomics strategies, including one based on SILAC and one based on isobaric mass tags. Over 1000 proteins were assayed for TAM- and NDT-induced protein stability changes, and a total of 163 and 200 protein hits were identified in the TAM and NDT studies, respectively. A subset of 27 high-confidence protein hits were reproducibly identified with both proteomics strategies and/or with multiple peptide probes. One-third of the high-confidence hits have previously established experimental links to the estrogen receptor, and nearly all of the high-confidence hits have established links to breast cancer. One high-confidence protein hit that has known estrogen receptor binding properties, Y-box binding protein 1 (YBX1), was further validated as a direct binding target of TAM using both the SPROX and pulse proteolysis techniques. Proteins with TAM- and/or NDT-induced expression level changes were also identified in the SILAC-SPROX experiments. These proteins with expression level changes included only a small fraction of those with TAM- and/or NDT-induced stability changes.

Indexed as

Breast NeoplasmsFemaleHumansMCF-7 CellsMolecular Targeted TherapyProtein FoldingProtein StabilityProteomeProteomicsReceptors, EstrogenTamoxifenY-Box-Binding Protein 1ProteomeReceptors, EstrogenTamoxifenY-Box-Binding Protein 1YBX1 protein, humanchemical denaturationiTRAQmass spectrometrymode of actionoff-targetproteomicspulse proteolysisSILACSPROXY-Box binding protein 1

Identifiers

PMID28927269
PMCPMC5695045
OpenAlexW2754737418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.